Donald Trump health update reveals detailed insights from his first physical exam of his second term. At 78, Trump is on ...

The president’s annual exam Friday showed normal vital signs and neurological functioning; it also noted scarring on his ear ...

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) (”Aspire” or the “Company”), a developer of a multi-faceted patent-pending drug delivery technology, today announced that Kraig Higginson, CEO of Aspire, ...

President Trump is in "excellent health," the White House physician said in a release following the president's annual ...

Compared with no treatment, aspirin use was associated with an increased risk for acute kidney injury (AKI) in critical patients with chest trauma, a new cohort study revealed. Nonsteroidal anti ...

"Based on these results, I hope that guidelines will address clopidogrel monotherapy as comparable to aspirin monotherapy or as preferred to aspirin monotherapy for patients at high risk of ...

25). After a median follow-up of over two years, patients taking clopidogrel were 29% less likely than those taking aspirin to experience the trial's primary composite endpoint of all-cause death ...

People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open blocked arteries, experienced significantly better outcomes with clopidogrel ...

Clopidogrel monotherapy was found to be more effective than aspirin monotherapy in lowering risk of major adverse cardiac and cerebrovascular events among patients at high risk of recurrent ischemic ...

Paracetamol, aspirin and ibuprofen are among the most widely used. While they are all effective for pain relief, they each work in a slightly different way and ideally, tackling different symptoms.

Aspirin, one of the world’s most common over-the-counter painkillers, could help fight cancer, a new study, published in Nature, a scientific journal, has discovered. Calling it a ‘Eureka moment’, ...